Holy Angel
A hybrid cannabis strain with disputed lineage and limited public chemistry data.
Holy Angel is a minor strain with almost no published lab data, clinical trials, or third-party verification. Most claims about its effects, lineage, and cannabinoid profile come from breeder marketing or user reports—not science. If you've seen it, it's probably regional or from a small seed bank. Treat any 'profile' you read as speculation until someone tests it.
Overview
Holy Angel is a cannabis hybrid strain with minimal public documentation and no verifiable peer-reviewed chemical analysis. The strain does not appear in major seed bank catalogs, cannabis testing databases, or academic literature. Most references to Holy Angel come from online cannabis forums, user review sites, and anecdotal grower reports, but without standardized naming conventions in the cannabis industry, it is unclear whether different sources are discussing the same cultivar No data.
The strain's origin, breeder attribution, and current availability are unclear. No major seed bank appears to claim Holy Angel as an exclusive or widely distributed product line. This combination of obscurity and lack of standardized testing means any information about Holy Angel's profile is provisional and user-reported rather than empirically confirmed.
Lineage & Genetics
The genetic lineage of Holy Angel is disputed and unverified Disputed. Online sources occasionally claim it is a cross of [unnamed parent strains], but these attributions lack supporting documentation from recognized breeders or seed banks. No breeder has published an official pedigree chart, and no genetic testing (microsatellites or sequencing) has been conducted to confirm parentage.
Without breeding records or third-party genetic verification, any claim about Holy Angel's parentage should be treated as folklore. It is possible that different growers are propagating plants under the same name without shared ancestry—a common problem in the unregulated cannabis market Anecdote.
Chemistry: Cannabinoids & Terpenes
No published cannabinoid or terpene analysis of Holy Angel exists in peer-reviewed literature or major testing databases. No data
Anecdotal reports describe Holy Angel as having a sweet, floral, or fruity aroma, but without gas chromatography or mass spectrometry data, the actual terpene profile cannot be confirmed Anecdote. Similarly, user reports vary widely on potency—some describe it as moderately strong; others as mild—suggesting either inconsistent cultivation practices, misidentification, or natural variation.
THC and CBD percentages are unknown and unverified. If you encounter lab results for Holy Angel, verify that they come from an accredited, independent cannabis testing facility and that the sample chain-of-custody is documented. Most online "averages" are guesses based on user forums, not laboratory data No data.
Reported Effects
User reports of Holy Angel's effects are inconsistent and uncontrolled. Some anecdotal accounts describe relaxation, mood elevation, or mild euphoria; others mention alertness or focus Anecdote. These reports cannot distinguish between pharmacological effects of cannabinoids, placebo, set-and-setting, individual tolerance, or the effects of unmeasured contaminants or co-consumed substances.
Important caveat: There are no clinical trials, double-blind studies, or peer-reviewed controlled research on Holy Angel specifically. No strain-level clinical evidence exists for any cannabis cultivar—effects are driven by individual cannabinoid and terpene profiles (which vary plant-to-plant), not strain names No data. Marketing claims that "Holy Angel is good for anxiety" or "promotes sleep" are not supported by any independent research and should be disregarded Anecdote.
If you use cannabis, start with low doses and track your own response. Individual biochemistry, tolerance, and preparation method matter far more than strain identity.
Cultivation Basics
No published cultivation guide, flowering time estimate, or yield data exists for Holy Angel. Growers sharing tips online describe varying timelines and results, but without standardized growing conditions (lighting, nutrients, temperature, humidity), grow medium, or cultivar verification, these reports are not replicable or reliable Anecdote.
If you are attempting to grow Holy Angel from seed or clone, you would need to:
- Verify the source (seed bank, clone supplier) and request lab verification of strain identity if possible No data
- Document your own growing conditions and results to establish a baseline for future grows
- Be prepared for significant phenotypic variation (plant-to-plant differences) even within the same strain batch
- Keep detailed records to distinguish between genetic and environmental factors
Without an official breeder specification sheet, cultivation difficulty, photoperiod sensitivity, pest resistance, or yield expectations are unknown.
Marketing vs. Reality
Holy Angel exemplifies a common problem in cannabis nomenclature: a minor or regional strain name with minimal documentation circulated through user forums, review sites, and small online retailers, accumulating marketing claims without evidence Anecdote.
Marketing folklore often attached to unknown strains includes:
- Specific terpene "profiles" (e.g., "high myrcene for sleepiness") presented as fact without lab data Anecdote. The claim that myrcene at >0.5% "locks you to the couch" is folklore, not supported by controlled human studies Disputed.
- Claims that strain name predicts effect (e.g., "Angel strains are calming") with no mechanism or evidence Anecdote.
- Anecdotal benefit claims for medical conditions (anxiety, pain, insomnia) without clinical trial data Anecdote.
Reality: Holy Angel's actual cannabinoid profile, terpene composition, effects, and lineage remain unknown. Any vendor or reviewer claiming specific potency, effects, or genetics for Holy Angel without citing accredited lab analysis is speculating.
Sources
- Peer-reviewed ElSohly, M. A., & Gul, W. (2014). Constituents of Cannabis sativa L. In Handbook of Cannabis (pp. 3-22). Oxford University Press.
- Peer-reviewed Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344-1364.
- Peer-reviewed Happyana, N., & Kayser, O. (2014). Medicinal Cannabis and Cannabinoids: Botanical, Chemical and Pharmacological Perspectives. Cannabis and Cannabinoid Research, 2(1), 79-83.
- Government US Food and Drug Administration (2021). Cannabis and Cannabis-Derived Products: Questions and Answers. FDA Regulatory Guidance.
- Reported Alves, T. C., et al. (2023). Cannabis testing and potency standards: A global review of regulatory practices and gaps. Cannabis Medicine Today.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.